Skip to main content
Fig. 1 | Molecular Cancer

Fig. 1

From: Coupled liquid biopsy and bioinformatics for pancreatic cancer early detection and precision prognostication

Fig. 1

Integrated strategies for detection of tumor from liquid biopsies. Various tumor-derived circulating components can be used as a source of liquid biopsies, including circulating cell-free DNA (cfDNA), circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), circulating tumor RNA (ctRNA), circulating miRNA, tumor-educated platelets (TEPs), extracellular vesicles (EVs), circulating tumor-derived proteins, and circulating metabolites. Each element can extract one or more levels of information about the genome, the transcriptome, the proteome or the metabolome.

Back to article page

Molecular Cancer

ISSN: 1476-4598